Weight loss drug waste: what happens to the Ozempic pens?

BMJ 2026

View at publisher
Authors: Mahima Adey
DOI: 10.1136/bmj.r2495
Cited by: 1
References: 8

Abstract

Pharmaceutical companies facing increasing demand for GLP-1 agonist receptors are struggling to minimise their impact on the environment. Mahima Adey reports

Fields of Study & Subjects

Potassium and Related Disorders Safe Handling of Antineoplastic Drugs Healthcare cost quality practices

Publication details

Journal / source
BMJ
Publisher
BMJ
Volume
392
Pages
r2495–r2495
Publication date
23 February 2026
Language
EN